MCA-PSV Calculator
Monochorionic diamniotic twins use the Klaritsch (2009) reference formula.
Enter gestational age in complete weeks. Singleton range: 14-40 weeks. MCDA twins: 18-36 weeks.
Days 0-6 beyond the completed weeks, for sub-week precision.
Enter the highest peak systolic velocity from at least 3 measurements, in cm/s.
Post-IUT threshold is 1.69 MoM instead of 1.50 MoM, due to donor erythrocyte effect on MCA velocity.
Enter MCA-PSV Values
Select gestational age and enter the measured MCA-PSV to calculate the MoM value and fetal anemia risk classification.
Important
This calculator is provided for general information only and is not medical advice, diagnosis, or treatment. Results are estimates based on population averages and cannot account for your individual circumstances. Speak to a qualified healthcare professional before acting on anything you read here.
Middle Cerebral Artery Peak Systolic Velocity — Fetal Anemia Risk Assessment
The MCA-PSV Calculator is a clinical decision-support tool for obstetricians, maternal-fetal medicine (MFM) specialists, perinatologists, and sonographers who need to assess fetal anemia non-invasively using middle cerebral artery Doppler measurements. This calculator converts a measured MCA peak systolic velocity (PSV, in cm/s) to a Multiple of the Median (MoM) adjusted for gestational age, then classifies the risk of fetal anemia according to internationally accepted clinical thresholds. Fetal anemia is a serious condition that can result from red blood cell alloimmunization (such as Rh disease), twin-to-twin transfusion syndrome, parvovirus B19 infection, alpha-thalassemia, or fetomaternal hemorrhage. Historically, assessing fetal anemia required invasive procedures such as cordocentesis (percutaneous umbilical blood sampling), which carries procedural risks. The landmark study by Mari et al., published in the New England Journal of Medicine in 2000, demonstrated that the MCA-PSV measured by Doppler ultrasound can detect moderate-to-severe fetal anemia with 100% sensitivity and a false-positive rate of only 12%, providing a reliable non-invasive alternative. The physiological basis for MCA-PSV monitoring is straightforward: in an anemic fetus, cardiac output increases to compensate for reduced oxygen-carrying capacity of the blood. This hyperdynamic circulation causes increased blood flow velocity in the cerebral vessels, particularly the middle cerebral artery. The MCA is ideal for measurement because it is easily accessible by ultrasound, has a predictable course, and its PSV correlates strongly with fetal hemoglobin levels (R² = 0.84, p < 0.0001). This calculator implements the primary singleton reference formula from Mari et al. (NEJM 2000): Median MCA-PSV = e^(2.31 + 0.046 × GA), where GA is gestational age in weeks. For monochorionic diamniotic (MCDA) twin pregnancies, the Klaritsch et al. (UOG 2009) formula is used: Median MCA-PSV = e^(2.17 + 0.049 × GA), since MCDA twins have lower baseline MCA velocities than singletons at the same gestational age. The MoM (Multiple of the Median) is calculated by dividing the measured MCA-PSV by the expected median for the given gestational age: MoM = Measured PSV / Median PSV. This normalization allows consistent interpretation across all gestational ages from 14 to 40 weeks. Anemia risk is classified into four tiers based on the MoM value: Normal (below 1.29 MoM) indicates routine surveillance; Mild possible anemia (1.29 to 1.49 MoM) warrants increased surveillance frequency; Moderate-to-severe anemia (1.50 to 1.54 MoM) requires consideration of cordocentesis or intrauterine transfusion (IUT); and Severe anemia (1.55 MoM or above) indicates urgent evaluation with intrauterine transfusion or delivery planning. Important clinical caveats: the 1.50 MoM threshold performs best between 18 and 35 weeks; the false-positive rate increases after 35 weeks. After an intrauterine transfusion, the threshold rises to 1.69 MoM because donor erythrocytes affect MCA-PSV values. Borderline measurements should be repeated after excluding fetal breathing movements or significant fetal activity, which can transiently elevate PSV. This tool also supports serial measurement tracking, allowing clinicians to record multiple PSV readings over time and visualize trends toward or away from the critical 1.5 MoM threshold. All calculations are performed locally in your browser — no patient data is transmitted to any server. This tool is intended for educational and clinical decision support purposes and does not replace formal clinical assessment by a qualified maternal-fetal medicine specialist.
Understanding MCA-PSV and Fetal Anemia
What Is MCA-PSV?
The middle cerebral artery peak systolic velocity (MCA-PSV) is a Doppler ultrasound measurement of the maximum blood flow speed through the middle cerebral artery of the fetus during systole (the heart's pumping phase). Measured in centimeters per second (cm/s), it reflects cardiac output and blood viscosity. In a normally grown, non-anemic fetus, MCA-PSV increases predictably with gestational age as the fetus grows and cardiac output increases. This predictable relationship, first described systematically by Mari and colleagues in 2000, forms the basis of MoM-based fetal anemia screening. MCA-PSV monitoring is now the standard of care for non-invasive fetal anemia surveillance in high-risk pregnancies worldwide.
How Is MoM Calculated?
The Multiple of the Median (MoM) is calculated by dividing the patient's measured MCA-PSV by the expected median value for the same gestational age. The expected median is derived from the Mari formula: Median = e^(2.31 + 0.046 × GA) for singletons, or e^(2.17 + 0.049 × GA) for MCDA twins (Klaritsch 2009). For sub-week precision, gestational age in days is added as a fraction: GA_exact = weeks + (days / 7). The resulting MoM value is dimensionless and allows comparison across gestational ages — a MoM of 1.50 means the measured PSV is 50% above the expected median, regardless of whether the patient is 20 or 32 weeks pregnant.
Why Does It Matter Clinically?
Before MCA-PSV Doppler became available, assessing fetal anemia required invasive cordocentesis, which carries a procedure-related fetal loss rate of 1-2%. The Mari et al. (NEJM 2000) study demonstrated that a MCA-PSV at or above 1.50 MoM identifies moderate-to-severe fetal anemia with 100% sensitivity, allowing clinicians to identify all cases requiring intervention while avoiding unnecessary invasive procedures in the majority of women. This transformation in clinical practice has saved thousands of fetuses from unnecessary invasive testing while ensuring that severely anemic fetuses receive timely intrauterine transfusion. MCA-PSV monitoring is now recommended by ACOG, SMFM, and ISUOG for surveillance of pregnancies at risk for fetal anemia.
Limitations and Clinical Caveats
MCA-PSV measurement has important technical and clinical limitations. Measurement accuracy depends critically on correct technique: the sample volume must be placed 2 mm from the ICA origin, the insonation angle must be 0 degrees, and the highest PSV from at least 3 measurements should be recorded. Fetal breathing movements, significant fetal activity, and maternal meals can transiently elevate PSV, causing false-positive results (overall false-positive rate 12%). Reliability decreases after 35 weeks' gestation, where the false-positive rate increases substantially. After intrauterine transfusion, the threshold rises to 1.69 MoM because donor erythrocytes (with normal hemoglobin) alter the MCA velocity pattern. This calculator provides decision support only and does not replace clinical assessment by a qualified maternal-fetal medicine specialist.
Formulas
The reference formula for singleton pregnancies from Mari et al. (NEJM 2000). GA is gestational age in weeks (with fractional days as GA + days/7). Returns the expected median MCA-PSV in cm/s for the given gestational age.
The reference formula for monochorionic diamniotic twin pregnancies from Klaritsch et al. (UOG 2009). MCDA twins have lower baseline MCA velocities than singletons, so using the singleton formula would systematically overestimate MoM.
Normalizes the measured MCA-PSV against the gestational-age-specific median. A MoM of 1.0 equals the expected median. Values at or above 1.50 MoM indicate moderate-to-severe anemia with 100% sensitivity (Mari et al.).
Reference Tables
Singleton MCA-PSV Reference Values by Gestational Age
| GA (weeks) | Median PSV (cm/s) | 1.29 MoM (cm/s) | 1.50 MoM (cm/s) | 1.55 MoM (cm/s) |
|---|---|---|---|---|
| 18 | 23.2 | 29.9 | 34.8 | 36.0 |
| 20 | 25.5 | 32.9 | 38.3 | 39.5 |
| 22 | 28.0 | 36.1 | 42.0 | 43.4 |
| 24 | 30.7 | 39.6 | 46.1 | 47.6 |
| 26 | 33.7 | 43.5 | 50.6 | 52.2 |
| 28 | 37.0 | 47.7 | 55.5 | 57.4 |
| 30 | 40.6 | 52.4 | 60.9 | 62.9 |
| 32 | 44.6 | 57.5 | 66.9 | 69.1 |
| 34 | 48.9 | 63.1 | 73.4 | 75.8 |
| 36 | 53.7 | 69.3 | 80.6 | 83.2 |
| 38 | 58.9 | 76.0 | 88.4 | 91.3 |
| 40 | 64.7 | 83.5 | 97.1 | 100.3 |
MoM Threshold Clinical Action Guide
| MoM Range | Classification | Clinical Action | Sensitivity |
|---|---|---|---|
| < 1.29 | Normal | Continue routine surveillance per protocol | N/A |
| 1.29 – 1.49 | Mild anemia possible | Increase surveillance frequency to 1–2 weeks | 88% for any anemia |
| 1.50 – 1.54 | Moderate-to-severe anemia | Consider cordocentesis and/or intrauterine transfusion | 100% for moderate-severe |
| ≥ 1.55 | Severe anemia | Urgent evaluation — IUT or delivery planning | 100% |
| ≥ 1.69 (post-IUT) | Post-transfusion threshold | Re-transfusion indicated if confirmed | Adjusted for donor RBCs |
Worked Examples
Singleton at 28 Weeks with Elevated PSV
Convert GA to decimal: 28 + 3/7 = 28.43 weeks
Calculate expected median (Mari formula): e^(2.31 + 0.046 × 28.43)
= e^(2.31 + 1.308) = e^3.618 = 37.3 cm/s
Calculate MoM: 56.2 / 37.3 = 1.51 MoM
MCDA Twins at 24 Weeks — TAPS Screening
GA = 24.0 weeks exactly
Calculate expected median (Klaritsch formula): e^(2.17 + 0.049 × 24.0)
= e^(2.17 + 1.176) = e^3.346 = 28.4 cm/s
Calculate MoM: 42.5 / 28.4 = 1.50 MoM
Post-IUT Follow-Up at 30 Weeks
GA = 30.0 weeks
Calculate expected median (Mari formula): e^(2.31 + 0.046 × 30.0)
= e^(2.31 + 1.38) = e^3.69 = 40.0 cm/s
Calculate MoM: 63.8 / 40.0 = 1.60 MoM
Compare to post-IUT threshold of 1.69 MoM: 1.60 < 1.69
How to Use the MCA-PSV Calculator
Select Gestational Age
Choose the gestational age in complete weeks using the dropdown (range: 14–40 weeks for singletons, 18–36 weeks for MCDA twins). For sub-week precision, also select the number of additional days (0–6). The calculator uses your exact gestational age to compute the expected median MCA-PSV from the Mari or Klaritsch formula.
Enter the Measured MCA-PSV
Type the highest peak systolic velocity in cm/s, recorded from at least 3 MCA Doppler measurements. Ensure the measurement was taken at 0° insonation angle, with the sample volume placed 2 mm from the ICA origin. Avoid measurements taken during fetal breathing or significant fetal activity, as these can falsely elevate the reading.
Select Pregnancy Type and Post-IUT Status
Toggle between Singleton (Mari formula) and MCDA Twins (Klaritsch formula). If the patient has recently received an intrauterine transfusion, enable the Post-IUT toggle — this adjusts the action threshold from 1.50 to 1.69 MoM, reflecting altered MCA-PSV physiology after donor erythrocyte transfusion.
Review MoM, Risk Classification, and Serial Trend
The calculator displays the MoM value, expected median, anemia risk classification, and a visual gauge showing your result relative to the 1.29, 1.50, and 1.55 MoM thresholds. Use the serial tracker to log multiple measurements over time and visualize the trend toward or away from the critical 1.50 MoM threshold. Export results as CSV for documentation or print for clinical records.
Frequently Asked Questions
What is the clinical significance of the 1.50 MoM threshold?
A MCA-PSV at or above 1.50 MoM is the primary clinical action threshold for fetal anemia. The landmark Mari et al. study (NEJM 2000) demonstrated that this cutoff detects moderate-to-severe fetal anemia — defined as hemoglobin more than two standard deviations below the mean for gestational age — with 100% sensitivity. The false-positive rate is 12%, meaning 1 in 8 fetuses classified as anemic at this threshold will not have true anemia on cordocentesis. This high sensitivity with acceptable false-positive rate makes it the standard of care for non-invasive fetal anemia surveillance, avoiding unnecessary invasive procedures in most cases while ensuring timely intervention for all genuinely anemic fetuses.
Why does the threshold change to 1.69 MoM after intrauterine transfusion?
After an intrauterine transfusion (IUT), the fetal circulation contains a mixture of the fetus's own erythrocytes (which may be anemic) and donor erythrocytes (with normal hemoglobin). This mixture has different viscosity and oxygen-carrying properties than pure fetal blood, altering the relationship between MCA-PSV and fetal hemoglobin. Studies have shown that after IUT, the same degree of true anemia produces a higher MCA-PSV than in non-transfused fetuses. Using the standard 1.50 MoM threshold post-IUT would lead to excessive false-positive diagnoses of recurrent anemia. The 1.69 MoM threshold has been validated for post-transfusion monitoring and should be applied until several weeks after the last transfusion.
How does this calculator differ for MCDA twin pregnancies?
In monochorionic diamniotic (MCDA) twin pregnancies, the baseline MCA-PSV is lower than in singleton pregnancies at the same gestational age, likely due to differences in hemodynamic adaptation in twins. Using the singleton Mari formula for MCDA twins would systematically overestimate the MoM, leading to false-positive anemia diagnoses. This calculator uses the Klaritsch et al. (UOG 2009) formula for MCDA twins: Median = e^(2.17 + 0.049 × GA), which was derived from a reference population of uncomplicated MCDA twin pregnancies. MCDA twins are particularly at risk for fetal anemia from twin-to-twin transfusion syndrome (TTTS) and twin anemia-polycythemia sequence (TAPS), making accurate MCA-PSV reference values especially important in this population.
What causes false-positive MCA-PSV results?
False-positive MCA-PSV readings (elevated MoM without true anemia) can occur in several situations. Fetal breathing movements and significant fetal activity transiently increase MCA blood flow velocity and should be waited out before measurement. Maternal meals within 1-2 hours of scanning can also increase fetal cerebral blood flow. Technical errors such as non-zero insonation angle, incorrect sample volume placement, or not selecting the highest of three measurements can give inconsistent results. After 35 weeks' gestation, the false-positive rate increases substantially, so MCA-PSV is less reliable in late pregnancy. Borderline results (MoM between 1.45 and 1.55) should be repeated within 24-48 hours before clinical decisions are made.
How often should MCA-PSV be measured in a high-risk pregnancy?
The monitoring frequency depends on the clinical indication and the most recent MoM value. For red blood cell alloimmunization, the AlloHope Foundation and SMFM guidance recommend initiating MCA-PSV surveillance at 16-18 weeks for high-risk cases (titer ≥ 1:16 for anti-D or any level for anti-Kell). If MoM is below 1.29, weekly measurements are standard. If MoM is approaching 1.4-1.49, reassessment every 2-3 days is appropriate. If MoM reaches or exceeds 1.50, immediate referral for cordocentesis and potential intrauterine transfusion is indicated. For TTTS and TAPS monitoring, frequency is guided by the stage of the syndrome and the treating MFM specialist's clinical judgment.
Can MCA-PSV be used before 18 weeks or after 35 weeks?
The Mari formula was validated primarily for gestational ages 18-40 weeks, and most clinical use is within this range. Some references, including Perinatology.com, extend the singleton range to 14 weeks. Our calculator supports 14-40 weeks for singletons following this extended range. However, clinical use below 18 weeks is less validated, and the clinical threshold of 1.50 MoM should be interpreted with caution. After 35 weeks, the false-positive rate increases significantly — the velocity increases more steeply with gestational age in late pregnancy than the Mari formula predicts, so apparent elevations in MoM are more likely to be false positives. Clinicians typically weigh the MCA-PSV result alongside amniotic fluid assessment and clinical context when interpreting results at advanced gestational ages.